Evidence map›Paper›PMID 25019686›Full record

ArticleNature communications2014

Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells.

Dominik Niopek, Dirk Benzinger, Julia Roensch, Thomas Draebing, Pierre Wehler, Roland Eils, Barbara Di Ventura

Abstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Characterizing Optogenetic Tools for Use in Synthetic Gene Circuits.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Hydraulic Activation of the AsLOV2 Photoreceptor.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Switchbody, an Antigen-Responsive Enzyme Switch Based on Antibody and Its Working Principle.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dominik Niopek1] German Cancer Research Center (DKFZ), Department of Theoretical Bioinformatics, Im Neuenheimer Feld 580, Heidelberg 69120, Germany [2] Department of Bioinformatics and Functional Genomics, Synthetic Biology Group, Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, University of Heidelberg, Im Neuenheimer Feld 267, Heidelberg 69120, Germany.
Dirk Benzinger1] Department of Bioinformatics and Functional Genomics, Synthetic Biology Group, Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, University of Heidelberg, Im Neuenheimer Feld 267, Heidelberg 69120, Germany [2].
Julia RoenschGerman Cancer Research Center (DKFZ), Department of Theoretical Bioinformatics, Im Neuenheimer Feld 580, Heidelberg 69120, Germany.
Thomas Draebing1] Department of Bioinformatics and Functional Genomics, Synthetic Biology Group, Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, University of Heidelberg, Im Neuenheimer Feld 267, Heidelberg 69120, Germany [2].
Pierre WehlerGerman Cancer Research Center (DKFZ), Department of Theoretical Bioinformatics, Im Neuenheimer Feld 580, Heidelberg 69120, Germany.
Roland Eils1] German Cancer Research Center (DKFZ), Department of Theoretical Bioinformatics, Im Neuenheimer Feld 580, Heidelberg 69120, Germany [2] Department of Bioinformatics and Functional Genomics, Synthetic Biology Group, Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, University of Heidelberg, Im Neuenheimer Feld 267, Heidelberg 69120, Germany.
Barbara Di VenturaDepartment of Bioinformatics and Functional Genomics, Synthetic Biology Group, Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, University of Heidelberg, Im Neuenheimer Feld 267, Heidelberg 69120, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The function of many eukaryotic proteins is regulated by highly dynamic changes in their nucleocytoplasmic distribution. The ability to precisely and reversibly control nuclear translocation would, therefore, allow dissecting and engineering cellular networks. Here we develop a genetically encoded, light-inducible nuclear localization signal (LINuS) based on the LOV2 domain of Avena sativa phototropin 1. LINuS is a small, versatile tag, customizable for different proteins and cell types. LINuS-mediated nuclear import is fast and reversible, and can be tuned at different levels, for instance, by introducing mutations that alter AsLOV2 domain photo-caging properties or by selecting nuclear localization signals (NLSs) of various strengths. We demonstrate the utility of LINuS in mammalian cells by controlling gene expression and entry into mitosis with blue light.

Indexed as

LightAvenaMutationNuclear Localization SignalsPhototropinsPlant ProteinsNuclear Localization SignalsPhototropinsPlant Proteins

Identifiers

PMID25019686
PMCPMC4104460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.